COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Cellular Senescence in Disease - 1st Edition - ISBN: 9780128225141

Cellular Senescence in Disease

1st Edition

Editors: Manuel Serrano Daniel Munoz-Espin
Paperback ISBN: 9780128225141
Imprint: Academic Press
Published Date: 1st October 2021
Page Count: 350
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Research in the field of senescence has boomed recently due to the gradual realization that senescent cells are associated with a significant number of diseases. The genetic or pharmacological elimination of senescent cells can cause widespread benefits and improves outcomes for most of those diseases. Cellular Senescence in Diseases presents an updated review of the role of cellular senescence in multiple pathologies. Focus is given to those diseases where the implication of senescence has been more extensively documented, such as (cancer, lung and liver diseases, diabetes, Neurodegenerative diseases and others).

The Editors recruited a group of worldwide experts in each individual pathology to review the role of cellular senescence in each one of them, aiming at identifying potential therapeutic pathways. The first two chapters provide an overview of the cellular senescence principles. Next, the chapters are divided into specific diseases. Cancer, including premalignant lesions (OIS), Advanced disease (TIS), and Metastasis are covered. The following condition covered is Lund diseases, including IPF, COPD, and Pulmonary Hypertension. Next Liver Diseases are covered, including Fibrosis and Cirrhosis, and Fatty liver disease. Next there is coverage for Kidney implications, including fibrosis and transplantation. Vascular diseases are covered next including infarction and hear fibrosis, and atherosclerosis. Both diabetes types 1 and 2 are covered next. Following chapters cover Obesity, Sarcopenia, and Bone and Cartilage disorders, respectively. Neurodegenerative diseases are covered next, focusing on Alzheimer and Parkinson. The next chapter discusses accumulation of senescent cell in tissues during aging. The two final chapters cover current developments and conclusions.

Cellular Senescence in Diseases is designed for researchers and clinicians with a focus on the cellular mechanisms of diseases. All chapters cover current experimental therapeutic approaches to eliminate or cancel the pathological effects of senescent cells. Pharmaceutical scientists may also benefit from the contents of the book in the exploration of novel therapeutic opportunities.

Key Features

  • Provides a thorough introduction to Cellular Senescence
  • Covers all major pathologies for which cellular senescence has shown evidence of involvement
  • Focuses on possible therapeutic pathways
  • Edited and authored by worldwide experts

Readership

Researchers and clinicians with a focus on the cellular mechanisms of diseases

Table of Contents

I. Fundamentals
1. Introduction to Cellular Senescence
2. Cellular and Molecular aspects

II. Cellular Senescence in Disease States
3. Cancer
4. Lung diseases
5. Liver diseases
6. Kidney diseases
7. Vascular diseases
8. Diabetes
9. Obesity
10. Sarcopenia
11. Bone and Cartilage Disorders
12. Neurodegenerative diseases
13. Accumulation of senescent cells in tissues during Aging

III. Conclusions
14. Current developments - where research is going
15. Conclusions

Details

No. of pages:
350
Language:
English
Copyright:
© Academic Press 2021
Published:
1st October 2021
Imprint:
Academic Press
Paperback ISBN:
9780128225141

About the Editors

Manuel Serrano

Dr. Manuel Serrano did his PhD under the supervision of Margarita Salas (CBM-CSIC, Madrid) and a postdoctoral stay in David Beach’s lab (Cold Spring Harbor Laboratory, NY, USA) from 1992 to 1996. During this time, he made one of his most important contributions, namely the discovery of the tumor suppressor p16. The main contributions of Dr. Serrano’s lab during these years are related to the concept of oncogene-induced senescence and the anti-ageing activity of tumor suppressors. More recently, his group has reported on the relevance of tumor suppressors in metabolic syndrome, the existence of senescence during embryonic development, and the feasibility of embryonic reprogramming within living adult organisms (the latter was considered "Achievement of the Year 2013" in the stem cells field by Nature Medicine).

Affiliations and Expertise

Parc Científic de Barcelona, Baldiri Reixa, Barcelona, Spain

Daniel Munoz-Espin

Dr. Daniel Munoz-Espin is Senior Research Associate at the Department of Oncology of the University of Cambridge. His lab is part of the CRUK Cambridge Centre Early Detection Programme, working at interface between cellular senescence, plasticity and the fundamental processes and mechanisms that lie at the origin of cancer. We are also developing novel tools and nanodevices for cancer therapy and diagnosis.

Affiliations and Expertise

Senior Research Associate, Department of Oncology, University of Cambridge, Cambridge, UK

Ratings and Reviews